New York, NY – New York's Columbia Presbyterian Hospital is hosting a mesothelioma clinical trial to determine if oxaliplatin plus gemcitabine, an experimental mesothelioma treatment, constitutes a viable first or second-line defense for patients who have been diagnosed with malignant peritoneal mesothelioma or malignant pleural mesothelioma. 

Physicians conducting this study with mesothelioma tests will seek to examine the rate at which tumors respond to this chemotherapy regimen. Researchers in this clinical trial for mesothelioma will also look to ascertain what the overall survival rate is for this course of treatment.

To receive this experimental mesothelioma treatment through this clinical trial, patients must not have undergone more than one additional form of chemotherapy treatment. If a patient has had a pleurodesis performed, than a two week interval must be observed between the performance of that procedure and participation in this mesothelioma clinical trial in New York.

In addition, patients who are still capable of reproduction must agree to use an approved method of contraception for the length of the study as well as for three months following the cessation of one's participation in it.

To find out more about this experimental mesothelioma treatment and study, please visit centerwatch.

To learn more about Columbia Presbyterian Hospital which host's one of the nation's foremost experts in the field of experimental mesothelioma tests and treatment, Dr. Robert N. Taub, please visit the New York Presbyterian Hospital website.

In the United States, asbestos is the only confirmed cause of mesothelioma. Typically, mesothelioma shows up at least fifteen years after a person's initial exposure to asbestos. Asbestos can cause mesothelioma even when the exposure occurs for a brief amount of time. Asbestos fibers are tiny and exposure can occur without an individual being aware of it.

Mesothelioma tests have proven that the disease is known to occur not only in the people working directly with asbestos products but also in bystanders or family member who were exposed to asbestos dust.

Experiments for treating mesothelioma provide hope and foresight into effectively treating the disease, however at this time asbestos is the only known cause of mesothelioma, a fatal cancer that occurs primarily in the lining of the lungs (pleural mesothelioma) and the abdomen (peritoneal mesothelioma).



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Ban Asbestos Now Act of 2017 proposed in Senate

At the end of October, the Environmental Protection Agency (EPA) announced it would be adjusting the...

EPA limits reach of toxic chemical evaluations

The EPA is reneging on promises to evaluate some of the most dangerous chemicals used by the public,...

Prevention remains the only way to end mesothelioma...

Mesothelioma is a deadly cancer that can affect the lining of the heart, the lining of the abdomen or,...

Controversial FACT Act headed to House floor for vote

The Furthering Asbestos Claim Transparency Act of 2017 (FACT Act) or H.R. 906, uses the guise of...
asbestos dust hazard perimeter tape

Canada joins countries implementing asbestos bans

Asbestos, a group of fibrous silicate minerals, is a known carcinogen and is closely linked to the...

Asbestos in schools poses mesothelioma risk. Who is...

According to the Environmental Protection Agency (EPA), approximately 15 million students and 1.4...

Impressed with the Beasley Allen staff

I am very impressed with the Beasley Allen staff. They were very courteous and patiently explained the aspects of my claim in a way I could understand. If I ever have any need of an attorney in the future I will turn to Beasley Allen.

—Philip